...
首页> 外文期刊>Japanese Journal of Ophthalmology >Transferrin-Polyethylenimine Conjugate, FuGENE6 and TransIT-LT as Nonviral Vectors for Gene Transfer to the Corneal Endothelium.
【24h】

Transferrin-Polyethylenimine Conjugate, FuGENE6 and TransIT-LT as Nonviral Vectors for Gene Transfer to the Corneal Endothelium.

机译:转铁蛋白-聚乙烯亚胺结合物,FuGENE6和TransIT-LT作为非病毒载体,用于基因转移到角膜内皮。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To investigate the efficacy and pathogenicity of three commercially available nonviral DNA vectors for gene transfer to the corneal endothelium.METHODS: Corneas obtained from New Zealand White rabbits were cultured ex vivo. For cell culture, the corneal endothelial cells were removed and cultured in vitro under standard conditions. Using the vectors, culture cells or ex vivo corneas were transfected with plasmid DNA coding for green fluorescent protein (GFP). Expression of the transduced gene was monitored by fluorescence microscopy. Transfection efficiency was estimated as the percentage of GFP-positive cells identified. The viability and morphology of the endothelium were also examined.RESULTS: Transferrin-polyethylenimine conjugate was effective in vitro but not ex vivo. FuGENE6 and TransIT-LT mediated the transfer of GFP gene both in in vitro and in ex vivo culture. Their efficiency estimated at day 3 was 28.8% and 38.8% in vitro, and 8.1% and 8.8% ex vivo, respectively. Viability staining revealed no dead cells. Morphological study showed no apparent alteration.CONCLUSIONS: FuGENE6 and TransIT-LT are safe, simple to use, and may be useful alternative methods for gene transfer to the corneal endothelium, avoiding certain side effects of viral vectors. As the efficiency could be enhanced, these nonviral vectors may be promising for practical application.
机译:目的:研究三种可商购的非病毒DNA载体将基因转移至角膜内皮的功效和致病性。方法:从新西兰白兔获得的角膜离体培养。对于细胞培养,去除角膜内皮细胞并在标准条件下体外培养。使用载体,用编码绿色荧光蛋白(GFP)的质粒DNA转染培养细胞或离体角膜。通过荧光显微镜监测转导的基因的表达。将转染效率估计为鉴定出的GFP阳性细胞的百分比。结果:转铁蛋白-聚乙烯亚胺偶联物在体外有效,但离体无效。 FuGENE6和TransIT-LT在体外和离体培养中均介导了GFP基因的转移。在第3天估计的体外效率分别为28.8%和38.8%,离体效率分别为8.1%和8.8%。活力染色显示无死细胞。结论:FuGENE6和TransIT-LT安全,易用,可能是将基因转移至角膜内皮的有用替代方法,避免了病毒载体的某些副作用。由于可以提高效率,因此这些非病毒载体在实际应用中可能很有希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号